These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32925542)

  • 21. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital Cytomegalovirus and HIV Perinatal Transmission.
    Adachi K; Xu J; Ank B; Watts DH; Camarca M; Mofenson LM; Pilotto JH; Joao E; Gray G; Theron G; Santos B; Fonseca R; Kreitchmann R; Pinto J; Mussi-Pinhata MM; Machado DM; Ceriotto M; Morgado MG; Bryson YJ; Veloso VG; Grinsztejn B; Mirochnick M; Moye J; Nielsen-Saines K;
    Pediatr Infect Dis J; 2018 Oct; 37(10):1016-1021. PubMed ID: 30216294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the timing of maternal antiretroviral therapy initiation, CD4 count, and HIV viral load on birth outcomes in the Eastern Cape province of South Africa: A secondary data analysis.
    Siqithi S; Durojaiye OC; Adeniyi OV
    PLoS One; 2024; 19(9):e0308374. PubMed ID: 39240844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa.
    Naicker N; Yende-Zuma N; Kharsany ABM; Shozi H; Nkosi D; Naidoo A; Garrett N; Abdool Karim SS
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):596. PubMed ID: 35883114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.
    Mphatswe W; Blanckenberg N; Tudor-Williams G; Prendergast A; Thobakgale C; Mkhwanazi N; McCarthy N; Walker BD; Kiepiela P; Goulder P
    AIDS; 2007 Jun; 21(10):1253-61. PubMed ID: 17545701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to Viral Suppression in Perinatally HIV-Infected Infants Depends on the Viral Load and CD4 T-Cell Percentage at the Start of Treatment.
    Schröter J; Anelone AJN; Yates AJ; de Boer RJ;
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):522-529. PubMed ID: 31917752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013.
    d'Arminio Monforte A; Galli L; Lo Caputo S; Lichtner M; Pinnetti C; Bobbio N; Francisci D; Costantini A; Cingolani A; Castelli F; Girardi E; Castagna A;
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):258-67. PubMed ID: 25314248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Why are HIV-infected infants still being born in Spain?].
    Fernández-Ibieta M; Ramos Amador JT; Guillén Martín S; González-Tomé MI; Navarro Gómez M; Iglesias González-Nicolás E; Rubio Gribble B; de José Gómez MI; Beceiro Mosquera J; Regidor J; De Santos Butragueño MJ; Martínez Guardia N; Roa Francia MA
    An Pediatr (Barc); 2007 Aug; 67(2):109-15. PubMed ID: 17692255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission.
    Bardeskar NS; Ahir-Bist SP; Mehta PR; Samant-Mavani P; Nanavati R; Mania-Pramanik J
    Arch Gynecol Obstet; 2020 Nov; 302(5):1229-1235. PubMed ID: 32803392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors associated with virological response in women receiving highly-active antiretroviral prophylaxis for HIV-1 mother-to-child transmission].
    Palacios R; Senise JF; Vaz MJ; Castelo A
    Enferm Infecc Microbiol Clin; 2008; 26(7):411-5. PubMed ID: 18842235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
    Fowler MG; Qin M; Fiscus SA; Currier JS; Flynn PM; Chipato T; McIntyre J; Gnanashanmugam D; Siberry GK; Coletti AS; Taha TE; Klingman KL; Martinson FE; Owor M; Violari A; Moodley D; Theron GB; Bhosale R; Bobat R; Chi BH; Strehlau R; Mlay P; Loftis AJ; Browning R; Fenton T; Purdue L; Basar M; Shapiro DE; Mofenson LM;
    N Engl J Med; 2016 Nov; 375(18):1726-1737. PubMed ID: 27806243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viraemia before, during and after pregnancy in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal, South Africa, 2010-2015.
    Chetty T; Newell ML; Thorne C; Coutsoudis A
    Trop Med Int Health; 2018 Jan; 23(1):79-91. PubMed ID: 29121445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    le Roux SM; Donald KA; Kroon M; Phillips TK; Lesosky M; Esterhuyse L; Zerbe A; Brittain K; Abrams EJ; Myer L
    Pediatr Infect Dis J; 2019 Jan; 38(1):70-75. PubMed ID: 30234792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the effects of maternal HIV infection on pregnancy outcomes using cross-sectional data in Malawi.
    Twabi HS; Manda SO; Small DS
    BMC Public Health; 2020 Jun; 20(1):974. PubMed ID: 32571265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the relationship between HIV drug resistance and CD4(+)T cell counts among antiretroviral therapy patients with low viral load].
    Liu PT; Xing H; Liao LJ; Leng XB; Wang J; Kan W; Yan J; Zuo ZB; Ruan YH; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):277-281. PubMed ID: 29973007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.